MANNKIND CORP Own-share Lending Arrangement, Shares, Outstanding
MANNKIND CORP (MNKD) had Own-share Lending Arrangement, Shares, Outstanding of 1.80 million shares as of 2015-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Debt › Own-share Lending Arrangement
us-gaap:OwnshareLendingArrangementSharesOutstanding · last filed 2018-02-27
- 2015-12-31: Own-share Lending Arrangement, Shares, Outstanding 1.80M shares; Own-share Lending Arrangement, Shares, Outstanding as first filed 9.00M shares.
- 2015-09-30: Own-share Lending Arrangement, Shares, Outstanding 9.00M shares.
- 2015-06-30: Own-share Lending Arrangement, Shares, Outstanding 9.00M shares.
- 2015-03-31: Own-share Lending Arrangement, Shares, Outstanding 9.00M shares.
| Period end | Own-share Lending Arrangement, Shares, Outstanding | Own-share Lending Arrangement, Shares, Outstanding as first filed |
|---|---|---|
| 2015-12-31 | 1.80M shares 10-K · filed 2018-02-27 | 9.00M shares 10-Q · filed 2016-11-09 |
| 2015-09-30 | 9.00M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 9.00M shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 9.00M shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 9.00M shares 10-K · filed 2015-03-02 | |
| 2014-09-30 | 9.00M shares 10-Q · filed 2014-11-10 | |
| 2014-06-30 | 9.00M shares 10-Q · filed 2014-08-11 | |
| 2014-03-31 | 9.00M shares 10-Q · filed 2014-05-12 | |
| 2013-12-31 | 9.00M shares 10-K · filed 2015-03-02 | |
| 2013-09-30 | 9.00M shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 9.00M shares 10-Q · filed 2013-08-09 | |
| 2013-03-31 | 9.00M shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 9.00M shares 10-K · filed 2015-03-02 | |
| 2012-09-30 | 9.00M shares 10-Q · filed 2012-11-09 | |
| 2012-06-30 | 9.00M shares 10-Q · filed 2012-08-09 | |
| 2011-12-31 | 9.00M shares 10-K · filed 2014-03-03 | |
| 2010-12-31 | 9.00M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |